Flow Diverting Stents in Aneurysm Treatment
Introduction to Flow Diverting Stents
- The American Heart Association/American Stroke Association (AHA/ASA) guidelines recommend avoiding the use of stents or flow diverters in patients with aneurysmal subarachnoid hemorrhage (aSAH) from ruptured saccular aneurysms amenable to either primary coiling or clipping due to higher risk of complications (Class 3: Harm; Level B-NR) 1
- Flow diverters should be reserved for specific cases, such as ruptured wide-neck aneurysms not amenable to surgical clipping or primary coiling (Class 2a; Level C-LD) 1
- Flow diverters are also recommended for ruptured fusiform/blister aneurysms (Class 2a; Level C-LD) 1
Technical Considerations
- The use of stent-assisted coiling and flow diverters has a higher risk of thrombogenicity than primary coiling, necessitating dual antiplatelet therapy 1
- There is a higher risk of hemorrhagic complications, particularly ventriculostomy-related hemorrhage, in ruptured aneurysms 1
- Follow-up imaging is complicated by metal artifacts from multiple stents, making surveillance more difficult 2
Patient Evaluation and Management
- Patients must be able to tolerate and comply with long-term dual antiplatelet therapy 1
- The ability to tolerate dual antiplatelet therapy and the need for long-term imaging surveillance should be considered when evaluating patients for flow diverter treatment 1
- The risk of parent vessel stenosis should also be considered when evaluating patients for flow diverter treatment 1